A. Marien

Implementation of a multi-parameter Point-of-Care-blood test analyzer reduces central laboratory testing and need for blood transfusions in very low birth weight infants.

L. Mahieu, J. De Dooy, V. Van Hoof, 2012, Clinica chimica acta; international journal of clinical chemistry.

Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors.

M. Janicot, L. van Hijfte, H. De Winter, 2005, European journal of medicinal chemistry.

The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation

B. Weir, U. Philippar, G. Cowley, 2022, Communications Biology.

Short Communication Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors

M. Janicot, Laurence Quéguiner, L. Hijfte, 2005 .